152 related articles for article (PubMed ID: 38306595)
1. Management of ALL in adults: 2024 ELN recommendations from a European expert panel.
Gökbuget N; Boissel N; Chiaretti S; Dombret H; Doubek M; Fielding A; Foà R; Giebel S; Hoelzer D; Hunault M; Marks DI; Martinelli G; Ottmann O; Rijneveld A; Rousselot P; Ribera J; Bassan R
Blood; 2024 May; 143(19):1903-1930. PubMed ID: 38306595
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel.
Gökbuget N; Boissel N; Chiaretti S; Dombret H; Doubek M; Fielding A; Foà R; Giebel S; Hoelzer D; Hunault M; Marks DI; Martinelli G; Ottmann O; Rijneveld A; Rousselot P; Ribera J; Bassan R
Blood; 2024 May; 143(19):1891-1902. PubMed ID: 38295337
[TBL] [Abstract][Full Text] [Related]
3. Acute lymphoblastic leukemia.
Alvarnas JC; Brown PA; Aoun P; Ballen KK; Bellam N; Blum W; Boyer MW; Carraway HE; Coccia PF; Coutre SE; Cultrera J; Damon LE; DeAngelo DJ; Douer D; Frangoul H; Frankfurt O; Goorha S; Millenson MM; O'Brien S; Petersdorf SH; Rao AV; Terezakis S; Uy G; Wetzler M; Zelenetz AD; Naganuma M; Gregory KM;
J Natl Compr Canc Netw; 2012 Jul; 10(7):858-914. PubMed ID: 22773801
[TBL] [Abstract][Full Text] [Related]
4. Recommendations for the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia: A consensus of North American experts.
Short NJ; Jabbour E; Albitar M; de Lima M; Gore L; Jorgensen J; Logan AC; Park J; Ravandi F; Shah B; Radich J; Kantarjian H
Am J Hematol; 2019 Feb; 94(2):257-265. PubMed ID: 30394566
[TBL] [Abstract][Full Text] [Related]
5. [Acute leukemia in adults].
Eigendorff E; Hochhaus A
Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
[TBL] [Abstract][Full Text] [Related]
6. A review of current induction strategies and emerging prognostic factors in the management of children and adolescents with acute lymphoblastic leukemia.
Capria S; Molica M; Mohamed S; Bianchi S; Moleti ML; Trisolini SM; Chiaretti S; Testi AM
Expert Rev Hematol; 2020 Jul; 13(7):755-769. PubMed ID: 32419532
[TBL] [Abstract][Full Text] [Related]
7. Recent approaches in acute lymphoblastic leukemia in adults.
Hoelzer D; Gökbuget N
Crit Rev Oncol Hematol; 2000 Oct; 36(1):49-58. PubMed ID: 10996522
[TBL] [Abstract][Full Text] [Related]
8. The changing scene of adult acute lymphoblastic leukemia.
Vitale A; Guarini A; Chiaretti S; Foà R
Curr Opin Oncol; 2006 Nov; 18(6):652-9. PubMed ID: 16988590
[TBL] [Abstract][Full Text] [Related]
9. [Acute lymphoblastic leukemia in the adult].
Gökbuget N
Dtsch Med Wochenschr; 2011 Dec; 136(48):2466-9. PubMed ID: 22109577
[No Abstract] [Full Text] [Related]
10. Eliminating a gold standard in childhood acute lymphoblastic leukemia?
Raetz EA; Carroll WL
Pediatr Blood Cancer; 2006 Sep; 47(3):242-4. PubMed ID: 16421903
[No Abstract] [Full Text] [Related]
11. Philadelphia-Like Acute Lymphoblastic Leukemia in Adults.
Herold T; Gökbuget N
Curr Oncol Rep; 2017 May; 19(5):31. PubMed ID: 28361222
[TBL] [Abstract][Full Text] [Related]
12. Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study.
Zhao H; Wei J; Wei G; Luo Y; Shi J; Cui Q; Zhao M; Liang A; Zhang Q; Yang J; Li X; Chen J; Song X; Jing H; Li Y; Hao S; Wu W; Tan Y; Yu J; Zhao Y; Lai X; Yin ETS; Wei Y; Li P; Huang J; Wang T; Blaise D; Xiao L; Chang AH; Nagler A; Mohty M; Huang H; Hu Y
J Hematol Oncol; 2020 May; 13(1):42. PubMed ID: 32366260
[TBL] [Abstract][Full Text] [Related]
13. [Treatment strategy for childhood acute lymphoblastic leukemia].
Horibe K
Rinsho Ketsueki; 2012 Oct; 53(10):1538-48. PubMed ID: 23037726
[No Abstract] [Full Text] [Related]
14. Role of minimal residual disease monitoring in adult and pediatric acute lymphoblastic leukemia.
Campana D
Hematol Oncol Clin North Am; 2009 Oct; 23(5):1083-98, vii. PubMed ID: 19825454
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and Therapeutic Targeting of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia.
Jeremias I; Schewe DM
Adv Exp Med Biol; 2018; 1100():127-139. PubMed ID: 30411264
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of minimal residual disease at the end of consolidation in NCI standard-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group.
Rau RE; Dai Y; Devidas M; Rabin KR; Zweidler-McKay P; Angiolillo A; Schore RJ; Burke MJ; Salzer WL; Heerema NA; Carroll AJ; Winick NJ; Hunger SP; Raetz EA; Loh ML; Wood BL; Borowitz MJ
Pediatr Blood Cancer; 2021 Apr; 68(4):e28929. PubMed ID: 33559396
[TBL] [Abstract][Full Text] [Related]
17. A simplified minimal residual disease polymerase chain reaction method at early treatment points can stratify children with acute lymphoblastic leukemia into good and poor outcome groups.
Scrideli CA; Assumpção JG; Ganazza MA; Araújo M; Toledo SR; Lee ML; Delbuono E; Petrilli AS; Queiróz RP; Biondi A; Viana MB; Yunes JA; Brandalise SR; Tone LG
Haematologica; 2009 Jun; 94(6):781-9. PubMed ID: 19483156
[TBL] [Abstract][Full Text] [Related]
18. Testing for minimal residual disease in adults with acute lymphoblastic leukemia in Europe: a clinician survey.
Pigneux A; Montesinos P; Cong Z; Zhang X; Pownell AK; Wieffer H; McKendrick J; Brüggemann M
BMC Cancer; 2018 Nov; 18(1):1100. PubMed ID: 30419861
[TBL] [Abstract][Full Text] [Related]
19. Detection and management of minimal residual disease in acute lymphoblastic leukemia.
Schrappe M
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):244-9. PubMed ID: 25696862
[TBL] [Abstract][Full Text] [Related]
20. Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008.
Brüggemann M; Schrauder A; Raff T; Pfeifer H; Dworzak M; Ottmann OG; Asnafi V; Baruchel A; Bassan R; Benoit Y; Biondi A; Cavé H; Dombret H; Fielding AK; Foà R; Gökbuget N; Goldstone AH; Goulden N; Henze G; Hoelzer D; Janka-Schaub GE; Macintyre EA; Pieters R; Rambaldi A; Ribera JM; Schmiegelow K; Spinelli O; Stary J; von Stackelberg A; Kneba M; Schrappe M; van Dongen JJ; ;
Leukemia; 2010 Mar; 24(3):521-35. PubMed ID: 20033054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
